Jeffrey  Mosebrook net worth and biography

Jeffrey Mosebrook Biography and Net Worth

Jeffrey Mosebrook serves as Senior Vice President, Principal Accounting Officer of the Company. He was appointed Principal Accounting Officer in October 2017. Mr. Mosebrook joined Integra in 2006 through Integra’s acquisition of Miltex, Inc. where he served as a financial reporting manager. Since joining Integra, he has served in a number of managerial positions with increasing responsibilities. In May 2010, he was named instruments Group Controller and went on to be named Group Controller, US in March 2012. In September 2014, Mr. Mosebrook was named as Vice President, Corporate Controller. Prior to Miltex, Inc., Mr. Mosebrook spent four years at Beard Miller Company, LLP (now known as Baker Tilly Virchow Krause, LLP) in various accounting roles. Mr. Mosebrook received a bachelor of science degree in accounting from York College and is a CPA licensed in Pennsylvania.

What is Jeffrey Mosebrook's net worth?

The estimated net worth of Jeffrey Mosebrook is at least $273,150.88 as of December 8th, 2022. Mr. Mosebrook owns 8,552 shares of Integra LifeSciences stock worth more than $273,151 as of April 17th. This net worth approximation does not reflect any other assets that Mr. Mosebrook may own. Learn More about Jeffrey Mosebrook's net worth.

How old is Jeffrey Mosebrook?

Mr. Mosebrook is currently 48 years old. There are 6 older executives and no younger executives at Integra LifeSciences. The oldest executive at Integra LifeSciences is Mr. Robert T. Davis Jr., Executive VP & President of Tissue Technologies, who is 65 years old. Learn More on Jeffrey Mosebrook's age.

How do I contact Jeffrey Mosebrook?

The corporate mailing address for Mr. Mosebrook and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected]. Learn More on Jeffrey Mosebrook's contact information.

Has Jeffrey Mosebrook been buying or selling shares of Integra LifeSciences?

Jeffrey Mosebrook has not been actively trading shares of Integra LifeSciences within the last three months. Most recently, Jeffrey Mosebrook sold 279 shares of the business's stock in a transaction on Thursday, December 8th. The shares were sold at an average price of $56.22, for a transaction totalling $15,685.38. Following the completion of the sale, the senior vice president now directly owns 8,552 shares of the company's stock, valued at $480,793.44. Learn More on Jeffrey Mosebrook's trading history.

Who are Integra LifeSciences' active insiders?

Integra LifeSciences' insider roster includes Richard Caruso (Major Shareholder), Glenn Coleman (COO), Jan De Witte (CEO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), Jeffrey Mosebrook (SVP), Raymond Murphy (Director), and Eric Schwartz (EVP). Learn More on Integra LifeSciences' active insiders.

Are insiders buying or selling shares of Integra LifeSciences?

In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 7,792 shares worth more than $299,992.00. The most recent insider tranaction occured on June, 1st when CEO Witte Jan De bought 7,792 shares worth more than $299,992.00. Insiders at Integra LifeSciences own 3.1% of the company. Learn More about insider trades at Integra LifeSciences.

Information on this page was last updated on 6/1/2023.

Jeffrey Mosebrook Insider Trading History at Integra LifeSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/8/2022Sell279$56.22$15,685.388,552View SEC Filing Icon  
8/2/2022Sell437$56.77$24,808.498,831View SEC Filing Icon  
3/2/2021Sell1,058$68.70$72,684.60
8/10/2018Sell1,000$62.42$62,420.003,085View SEC Filing Icon  
11/20/2017Sell160$47.41$7,585.60View SEC Filing Icon  
See Full Table

Jeffrey Mosebrook Buying and Selling Activity at Integra LifeSciences

This chart shows Jeffrey Mosebrook's buying and selling at Integra LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Integra LifeSciences Company Overview

Integra LifeSciences logo
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Read More

Today's Range

Now: $31.94
Low: $31.83
High: $32.34

50 Day Range

MA: $37.32
Low: $31.82
High: $45.20

2 Week Range

Now: $31.94
Low: $31.57
High: $59.11

Volume

645,897 shs

Average Volume

647,643 shs

Market Capitalization

$2.51 billion

P/E Ratio

38.48

Dividend Yield

N/A

Beta

1.12